MRG-001 not checked

MedRegen LLC

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
1 active
5 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“Patients will receive subcutaneous administration of MRG-001 at designated visits.”In the company’s words, NCT06307522 on ClinicalTrials.gov
Tested for
Alcoholic Hepatitis, Acute Alcoholic Hepatitis
Main trialPhase 2
“The goal of this study is to test MRG-001 (an experimental medication). The purpose of this trial is to assess the dose related safety, Pharmacokinetics, and Pharmacodynamics of MRG-001 in patients with severe alcoholic hepatitis (AH).”In the company’s words, NCT06307522 on ClinicalTrials.gov

Other drugs for Alcoholic Hepatitis

All 4 drugs for Alcoholic Hepatitis

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials5

TrialPhaseCompletesWhat it tests
Phase 2Not yet recruiting 1 Sep 2026 MRG-001 in Patients With Alcoholic Hepatitis
Phase 2Unknown 31 Mar 2022 MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients
Phase 2Completed 1 Sep 2024 Safety and Efficacy of MRG-001 in Wound Healing in Abdominoplasty Patients
Phase 2Unknown 1 Jan 2026 MRG-001 in Patients With Amyotrophic Lateral Sclerosis
Phase 2Unknown 1 Feb 2026 MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow MRG-001

Following is part of Solo: you see every change to MRG-001 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in